2.3. SPARC Is Differentially Expressed in NAFLD Patients and SPARC-Positively Correlated Genes Are Associated with Inflammasome-Related Pathways throughout the Progression of NAFLD. This evidence concerns the gene SPARC and metabolic dysfunction-associated steatotic liver disease.